Universal Copy Service, a popular software suite utilized by medical laboratories for DNA sequencing, has been found to have two high-severity vulnerabilities that could allow hackers to take over targeted endpoints and extract sensitive data. According to a joint security advisory from the US Cybersecurity Infrastructure Security Agency (CISA) and the FDA, an unauthenticated malicious actor could remotely upload and execute code at the operating system level, allowing them to modify settings, configurations, software, or access sensitive data on the affected product. Developed by California-based medical technology company Illumina, the software is used by research organizations, academic institutions, biotechnology firms, and pharmaceutical companies in 140 countries.
